Novo Nordisk has hired multiple lobbying firms to persuade lawmakers to take a harder line on companies producing versions of the drugs that have not been approved by the FDA
Ozempic maker spending more than $3m to lobby fat cats in Washington as weight-loss drugs faces regulatory decisions … from the Independent Mike Bedigan
